Stock Fundamentals

Company Information

Company Name
Immunome Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US45257U1088
CIK: 0001472012
CUSIP: 45257U108
Currency: USD
Full Time Employees: 206
Phone: 425 939 7410
Fiscal Year End: December
IPO Date: Oct 02, 2020
Description:

Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.

Address:

18702 North Creek Parkway, Bothell, WA, United States, 98011

Directors & Officers

Name Title Year Born
Dr. Clay B. Siegall Ph.D. Chairman, President & CEO 1961
Mr. Max Rosett Chief Financial Officer 1990
Dr. Robert J. Lechleider M.D. Chief Medical Officer 1961
Dr. Philip Tsai Chief Technical Officer 1968
Dr. Jack Higgins Ph.D. Chief Scientific Officer 1980
Ms. Sandra G. Stoneman Esq., J.D. Chief Legal Officer, General Counsel & Corporate Secretary 1973
Mr. Kinney Horn Chief Business Officer 1975
Mr. Roee Shahar Executive Vice President of Commercial NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 02, 2026 Jack Higgins N/A Sale 9.44K $21.64 $204.24K
Apr 02, 2026 Max Rosett N/A Sale 65.00K $21.92 $1.42M
Mar 23, 2026 Philip Wagenheim N/A Sale 28.20K $20.65 $582.33K
Mar 20, 2026 Philip Wagenheim N/A Sale 36.80K $20.47 $753.30K
Mar 11, 2026 Jean Jacques Bienaime N/A Purchase 1.00K $21.55 $21.55K
Dec 30, 2025 Clay B Siegall N/A Purchase 4.73K $21.15 $100.02K
Dec 22, 2025 Isaac Barchas N/A Sale 383.20K $21.74 $8.33M
Dec 19, 2025 Clay B Siegall N/A Purchase 7.28K $20.48 $149.05K
Dec 19, 2025 Philip Tsai N/A Purchase 10.00K $20.49 $204.90K
Dec 18, 2025 Clay B Siegall N/A Purchase 46.51K $21.50 $999.99K
Jun 03, 2025 Jean Jacques Bienaime N/A Purchase 5.00K $9.38 $46.90K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
FMR Inc 16.97M Mar 31, 2026 14.98% $0.02 2.54%
T. Rowe Price Investment Management,Inc. 16.36M Mar 31, 2026 14.45% $0.25 11.79%
BlackRock Inc 8.17M Mar 31, 2026 7.21% $0.00 7.55%
Vanguard Group Inc 6.04M Dec 31, 2025 5.33% $0.00 23.39%
Redmile Group, LLC 5.56M Mar 31, 2026 4.91% $8.05 -2.79%
State Street Corp 5.40M Mar 31, 2026 4.77% $0.00 39.60%
PRIMECAP Management Company 4.79M Mar 31, 2026 4.23% $0.08 2.19%
Wellington Management Company LLP 4.73M Mar 31, 2026 4.18% $0.02 406.38%
Vanguard Capital Management, LLC 4.43M Mar 31, 2026 3.91% $0.00 0.00%
Driehaus Capital Management LLC 4.10M Mar 31, 2026 3.62% $0.66 10.63%
Enavate Sciences GP, LLC 3.61M Mar 31, 2026 3.19% $22.48 -24.22%
T. Rowe Price Associates, Inc. 2.86M Mar 31, 2026 2.52% $0.01 -15.42%
Morgan Stanley - Brokerage Accounts 2.84M Mar 31, 2026 2.51% $0.00 66.26%
JPMorgan Chase & Co 2.78M Mar 31, 2026 2.45% $0.00 -2.73%
Geode Capital Management, LLC 2.56M Mar 31, 2026 2.26% $0.00 8.44%
SILVERARC CAPITAL MANAGEMENT, LLC 1.85M Mar 31, 2026 1.63% $4.13 64.29%
Readystate Asset Management LP 1.84M Dec 31, 2025 1.63% $1.61 39.82%
Sofinnova Ventures 1.70M Mar 31, 2026 1.50% $1.41 5.15%
Woodline Partners LP 1.58M Mar 31, 2026 1.39% $0.13 0.00%
Marshall Wace Asset Management Ltd 1.48M Mar 31, 2026 1.31% $0.03 100.89%

Shares Statistics

Shares Outstanding: 113.25M
Shares Float: 108.33M
% Insiders: 630.30%
% Institutions: 10,835.40%
Short % Float: 17.42%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Growth Compy Commingled Pl S 6.51M 5.75% ▲ 0.20% Apr 30, 2026
2 T. Rowe Price Small-Cap Stock 6.03M 5.32% ▲ 4.57% Apr 30, 2026
3 T. Rowe Price US Small-Cap Core Equity 5.76M 5.09% ▲ 12.42% Mar 31, 2026
4 Fidelity Growth Company Fund 4.74M 4.19% ▲ 0.11% Apr 30, 2026
5 PRIMECAP Odyssey Aggressive Growth 3.87M 3.42% ▲ 1.39% Mar 31, 2026
6 State Street® SPDR® S&P® Biotech ETF 3.25M 2.87% ▼ 0.61% May 31, 2026
7 T. Rowe Price Instl Small-Cap Stock 3.23M 2.85% ▲ 3.48% Apr 30, 2026
8 Vanguard Total Stock Mkt Idx Inv 3.18M 2.81% ▲ 0.36% Apr 30, 2026
9 T. Rowe Price U.S. SC Core Eq Tr-D 2.79M 2.46% ▲ 18.19% Mar 31, 2026
10 Vanguard Health Care Inv 2.78M 2.45% ▲ 0.00% Mar 31, 2026

Valuation Metrics

Enterprise Value: $1.50B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $2.08B
EBITDA: $-226.35M
Book Value: $5.20
Earnings/Share: $-2.39
Profit Margin: 0.00%
Operating Margin: -5,698.83%
ROA (TTM): -29.72%
ROE (TTM): -50.14%
Revenue (TTM): $4.02M
Revenue/Share (TTM): $0.04
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 14.69x 0.00x 0.07x N/A 0.00x
2024-12-31 4.08x 0.00x 0.25x N/A 0.00x
2023-12-31 6.63x 0.00x 0.19x N/A -0.01x
2022-12-31 3.09x 0.01x 0.31x -7,380.20x -0.01x
2021-12-31 5.82x 0.01x 0.17x -2,520.40x -0.01x
2020-12-31 14.12x 0.01x 0.07x -322.66x -0.05x
2019-12-31 1.88x -0.02x 8.04x -97.62x -0.06x
2018-12-31 1.35x -0.04x 6.67x -54.91x -0.13x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about IMNM.US!